Review
Accepted on 11 Feb 2025
NLRP3 Inflammasome in cardiovascular diseases: an update
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550226
- Frontiers in Immunology
- Inflammation
- Articles
Type at least 3 characters
4,923 articles
Articles
Original Research
Accepted on 11 Feb 2025
Identify the potential target of efferocytosis in knee osteoarthritis synovial tissue: a bioinformatics and machine learning-based study
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550794
Editorial
Published on 11 Feb 2025
Editorial: Hiding features in myeloid cells: metabolism preference in different disease models
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565258
Original Research
Accepted on 10 Feb 2025
ARHGAP25: a Novel Player in the Pathomechanism of Allergic Contact Hypersensitivity.
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1509713
Original Research
Accepted on 10 Feb 2025
Gene Regulation and Signaling Pathways in Immune Response to Respiratory Sensitizers: A Database Analysis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1470602
Review
Accepted on 10 Feb 2025
A New Perspective on the Regulation of Neuroinflammation in Intracerebral hemorrhage: Mechanisms of NLRP3 Inflammasome Activation and Therapeutic Strategies
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1526786
Editorial
Accepted on 10 Feb 2025
Editorial: Community series in Unveiling Immunological Mechanisms of Periodontal Disease
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571093
Review
Accepted on 10 Feb 2025
The various roles of TREM2 in cardiovascular disease
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1462508
Editorial
Published on 10 Feb 2025
Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1563584
- 200 views
Review
Published on 10 Feb 2025
The role of the interleukin family in liver fibrosis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1497095
- 184 views
Original Research
Accepted on 07 Feb 2025
Immune-Related Diagnostic Indicators and Targeted Therapies for COPD Combined with NASH were Identified and Verified via WGCNA and LASSO
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514422
- 160 views
Original Research
Published on 07 Feb 2025
The role of natural exosomes from SHED-MSC in immunoregulation of M0/M1 polarized macrophage cells
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1550280
- 327 views
Review
Published on 07 Feb 2025
CD109, a master regulator of inflammatory responses
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1505008
- 450 views
Review
Published on 07 Feb 2025
Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1425901
- 290 views
Mini Review
Published on 07 Feb 2025
Mitochondrial DNA in atherosclerosis research progress: a mini review
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1526390
- 301 views
Original Research
Published on 07 Feb 2025
Bradykinin B1 receptor signaling triggers complement activation on endothelial cells
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1527065
- 353 views